April 30, 2015
…reformulation of an existing drug was developed by Raptor Pharmaceuticals and became a breakthrough treatment for the orphan disease nephropathic cystinosis. “The Tech Transfer Office made it a completely seamless process for us.” Jane Moores, who has directed TTO since 2007, credited UC San Diego innovators, company partners and entrepreneurs…
June 11, 2021
UC San Diego School of Medicine researchers discovered gene expression patterns associated with pandemic viral infections, providing a map to help define patients’ immune responses, measure disease severity, predict outcomes and test therapies — for current and future pandemics.
March 17, 2022
UC San Diego study shows neuroendocrine cells in the lungs drive a developmental lung disease, and a similar brain-lung interaction may contribute to COVID-19 symptoms. The findings suggest neuropeptides may be a promising therapeutic target for conditions with excess lung fluid.
August 20, 2020
…as well as alcohol, drug and tobacco abuse, said Cachay. Photo credit: National Institute of Allergy and Infectious Diseases, NIH “When the response to COVID-19 came, rightfully so, we were asked to social distance,” said Cachay. “Ironically, our patients became more isolated, lonelier than ever, and raised more questions about…
January 26, 2023
Recognizing exceptional support to the campus, UC San Diego announced Karen and Jeff Silberman; the Step Family; and Sandra Timmons ’81 and Richard Sandstrom ’72, PhD ’79, as recipients of the 2022 Chancellor’s Medal. T. Denny Sanford is being recognized with the second-ever Lifetime Legacy Award.
October 18, 2018
…and personalized medicine to developing new technologies to study the mind and brain.” Many of this year’s notable awards help fund interdisciplinary studies throughout UC San Diego, including Moores Cancer Center. An $18 million grant from the California Institute for Regenerative Medicine will fund a clinical trial for a novel…
July 26, 2021
The UC San Diego Foundation Board of Trustees works to connect the university with community partners and resources needed to launch innovative programs. On July 1, 2021, nine new trustees joined the Foundation Board, eight of whom are UC San Diego alumni.
September 21, 2023
UC San Diego engineers have devised a new solution to control a major agricultural menace, root-damaging nematodes. Using plant viruses, they created nanoparticles that can deliver pesticides to previously unreachable soil depths. This could potentially minimize environmental toxicity and costs.
June 21, 2013
The academic landscape is changing rapidly, due in no small part to recent advances in technologies to enable, enhance and deliver teaching and learning to a worldwide audience.
November 12, 2021
…Two are Food and Drug Administration (FDA)-approved Phase 1 clinical safety trials for investigational compounds to treat acute COVID-19. Turkey tail is one of the medicinal mushrooms the MACH-19 trial will evaluate for its possible benefit in treating acute COVID-19 infection. “Mushroom-Based Product for COVID-19,” which started December 2020 and…
